Literature DB >> 7453102

Norepinephrine clearance and pressor effect in normal and hypertensive man.

M Grimm, P Weidmann, G Keusch, A Meier, Z Glück.   

Abstract

Whether and to what extent the sympathetic nervous system participates in the development of essential hypertension has remained largely unclear. The role of the adrenergic effector - cardiovascular response axis in the pathogenesis of essential hypertension was investigated by combined analysis of blood levels, total plasma clearance and cardiovascular pressor effects of norepinephrine (NE). Measurements of plasma NE and blood pressure were performed before, during and after an intravenous infusion of NE at stepwise increasing rates in approximately age and sex-matched groups of 28 normal subjects and 35 patients with essential hypertension. The threshold of the pressor effect of NE was lower in hypertensive than in normal subjects (20 +/- 10 vs. 42 +/- 26 ng/kg min; P < 0.001); but the slope of the dose - resonse curve and basal endogenous plasma NE were in the average similar. Total plasma NE clearance estimated under steady state conditions was similar in normal and hypertensive subjects (5.3 +/- 2.5 vs. 5.4 +/- 2.31/min). NE clearance corrleated inversely with basal plasma NE in normal subjects (r = 0.57; P < 0.005). The plasma half-life of NE was about 2 min. These findings demonstrate that basal blood levels and total plasma clearance of NE during NE infusion are usually normal in essential hypertension. A low threshold of the pressor effect of NE in the presence of normal adrenergic activity may contribute to the development and/or maintenance of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7453102     DOI: 10.1007/bf01478873

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  21 in total

1.  Essential hypertension and inheritance of vascular reactivity.

Authors:  A E DOYLE; J R FRASER
Journal:  Lancet       Date:  1961-09-02       Impact factor: 79.321

2.  The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension.

Authors:  M GOLDENBERG; K L PINES
Journal:  Am J Med       Date:  1948-12       Impact factor: 4.965

3.  Diminished baroreflex sensitivity in high blood pressure.

Authors:  J D Bristow; A J Honour; G W Pickering; P Sleight; H S Smyth
Journal:  Circulation       Date:  1969-01       Impact factor: 29.690

4.  The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension.

Authors:  K Abe; M Yasujima; N Irokawa; M Seino; S Chiba; Y Sakurai; M Sato; Y Imai; K Saito; T Ito; T Haruyama; Y Otsuka; K Yoshinaga
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

5.  Pathogenic and therapeutic significance of cardiovascular pressor reactivity as related to plasma catecholamines in borderline and established essential hypertension.

Authors:  P Weidmann; M Grimm; A Meier; Z Glück; G Keusch; I Minder; C Beretta-Piccoli
Journal:  Clin Exp Hypertens       Date:  1980       Impact factor: 1.749

6.  Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension.

Authors:  P Weidmann; C Beretta-Piccoli; W H Ziegler; G Keusch; Z Glück; F C Reubi
Journal:  Kidney Int       Date:  1978-12       Impact factor: 10.612

7.  The kinetics of plasma noradrenaline in normal and hypertensive subjects.

Authors:  S Ghione; C Palombo; M Pellegrini; E Fommei; A Pilo; L Donato
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

8.  Circulating catecholamine levels in human and experimental hypertension.

Authors:  J de Champlain; L Farley; D Cousineau; M R van Ameringen
Journal:  Circ Res       Date:  1976-02       Impact factor: 17.367

9.  PLASMA CLEARANCE OF DL-BETA-H3-NOREPINEPHRINE IN NORMAL HUMAN SUBJECTS AND PATIENTS WITH ESSENTIAL HYPERTENSION.

Authors:  S E GITLOW; M MENDLOWITZ; E K WILK; S WILK; R L WOLF; N E NAFTCHI
Journal:  J Clin Invest       Date:  1964-10       Impact factor: 14.808

10.  Plasma-noradrenaline in essential hypertension.

Authors:  P S Sever; B Osikowska; M Birch; R D Tunbridge
Journal:  Lancet       Date:  1977-05-21       Impact factor: 79.321

View more
  11 in total

1.  [Correlations between hemodynamic parameters and plasma catecholamines in normo- and hypertensive subjects at rest and during physical exercise].

Authors:  M Lehmann; J Keul
Journal:  Klin Wochenschr       Date:  1983-04-15

2.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

3.  Plasma catecholamine modulation of alpha 2 adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets.

Authors:  A S Hollister; J Onrot; S Lonce; J H Nadeau; D Robertson
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Total body, systemic and pulmonary clearance and fractional extraction of unlabelled and differently 3H-labelled noradrenaline in the anaesthetized rabbit.

Authors:  T Halbrügge; A L Ungell; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

5.  Risk of methylphenidate-induced prehypertension in normotensive adult smokers with attention deficit hyperactivity disorder.

Authors:  Arthur N Westover; Paul A Nakonezny; Theresa Winhusen; Bryon Adinoff; Wanpen Vongpatanasin
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-14       Impact factor: 3.738

6.  Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d,l-[3H]isoproterenol kinetics in essential hypertension.

Authors:  D S Goldstein; D Horwitz; H R Keiser; R J Polinsky; I J Kopin
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

7.  Correction of altered noradrenaline reactivity in essential hypertension by indapamide.

Authors:  M Grimm; P Weidmann; A Meier; G Keusch; W Ziegler; Z Glück; C Beretta-Piccoli
Journal:  Br Heart J       Date:  1981-10

8.  Total plasma clearance of infused norepinephrine in non-azotemic diabetes mellitus.

Authors:  C Beretta-Piccoli; P Weidmann
Journal:  Klin Wochenschr       Date:  1982-06-01

9.  Urinary excretion of free noradrenaline and adrenaline related to age, sex and hypertension in 265 individuals.

Authors:  M Lehmann; J Keul
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

10.  Antihypertensive mechanism of the diuretic muzolimine in mild renal failure. Roles of sodium and cardiovascular norepinephrine responsiveness.

Authors:  H Schiffl; P Weidmann; C Beretta-Piccoli; C Cottier; A J Seiler; W H Ziegler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.